Senores Pharmaceuticals issues ₹62 crore corporate guarantee for subsidiary
Senores Pharmaceuticals issued a ₹62 crore corporate guarantee on August 24, 2026. The facility secures credit lines for subsidiary Apnar Pharma Private Limited from ICICI Bank. Promoters have directorship interest in the subsidiary; transaction is at arm's length. The guarantee appears as a contingent liability with no immediate financial impact.
*this image is generated using AI for illustrative purposes only.
Senores Pharmaceuticals issued a corporate guarantee of ₹62 crore on August 24, 2026. The instrument secures credit facilities availed by its subsidiary, Apnar Pharma Private Limited, from ICICI Bank Limited.
The company disclosed the transaction pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. The filing references SEBI Circular No HO/49/14/14(7)2025-CFD-POD2/I/3762/2026 dated January 30, 2026.
Transaction Details
The guarantee remains valid until the closure of the underlying credit facilities. Senores Pharmaceuticals stated that the arrangement is at arm’s length. Promoters and the promoter group hold directorship interests in Apnar Pharma but no other specified interest in the transaction.
| Particulars | Details |
|---|---|
| Beneficiary | ICICI Bank Limited |
| Subsidiary | Apnar Pharma Private Limited |
| Guarantee Amount | ₹62 crore |
| Validity | Till closure of credit facilities |
Financial Impact
The company reported no immediate financial impact from this guarantee. The obligation will be disclosed in financial statements as a contingent liability.
Deval Rajnikant Shah, Whole-Time Director and CFO, signed the intimation filed with BSE and NSE.
Historical Stock Returns for Senores Pharmaceuticals
| 1 Day | 5 Days | 1 Month | 6 Months | 1 Year | 5 Years |
|---|---|---|---|---|---|
| +0.16% | +2.57% | +7.96% | +90.94% | +117.04% | +172.09% |
How will the ₹62 crore contingent liability affect Senores Pharmaceuticals' debt-to-equity ratio and future borrowing capacity?
What specific expansion or operational projects is Apnar Pharma Private Limited funding with these ICICI Bank credit facilities?
Could this guarantee signal a broader strategy by Senores Pharmaceuticals to consolidate its subsidiary operations through increased financial backing?
20
Access 50+ Readymade Screeners 
Use 200+ Custom Filters 
Get Full Market Insights 
